Muriel Danten

Associate Director Biostatistician
Merck Santé S.A.S., an affiliate of the healthcare business of Merck KGaA, Darmstadt, Germany, France

Poster(s):

• (C-184) Post-approval pregnancy safety evidence for signal identification: Comparison of preliminary results from two methodological approaches for high-efficacy drugs contraindicated during pregnancy
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET